Market Research Logo

Kidney Stones Management Market Size By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine) By Diagnostics (Abdominal X-ray, Computed Tomography Scan, Ultrasound, Abdominal MRI, Intravenous Pyleography, Others) By Treatment (Extracorp

Kidney Stones Management Market Size By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine) By Diagnostics (Abdominal X-ray, Computed Tomography Scan, Ultrasound, Abdominal MRI, Intravenous Pyleography, Others) By Treatment (Extracorporeal shock wave lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy, Others) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE) Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Kidney Stones Management Market will exceed USD 2 billion by 2024; as per a new research report.

A large number of people being affected by kidney stones worldwide should accelerate the kidney stone management market during forecast period. As per statistics, kidney stone disease affects as large as 10% of population in industrialized countries, while recurrent stone formation being a common part of the medical care of patients with stone diseases.

The introduction of minimally invasive procedures has revolutionized the field of kidney stone treatment due to benefits obtained which include shorter hospital stay, fast recovery, less traumatic pain, and fewer pain medicines. Various minimally invasive ureteroscopic, robotic, and laparoscopic surgeries are gaining momentum for kidney stones treatment since last few years accelerating the kidney stones management market growth.

Various organizational initiatives have led to a rise in awareness amongst the population regarding importance of kidney health. A global kidney health awareness campaign was initiated in 2006 known as World Kidney Day by the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF) to raise awareness regarding diagnosis and treatment of kidney related diseases. Under this campaign a large number of diabetes and hypertension patients undergo screening for kidney diseases, thus improving the diagnosis rate.

Calcium oxalate dominated the worldwide kidney stones management market in the year 2017. More than 75% of total kidney stone cases are found to be calcium phosphate and calcium oxalate stones. A large intake of foods that are rich in oxalate along with low fluids consumption is one of the pivotal causes of such stone formation in the body.

Computed tomography scan generated highest revenue in 2017. The largest share of the segment is accredited to extensive use of CT scan in kidney stones diagnosis due to its accuracy and ability to detect small size kidney stones. However, ultrasound has developed to be similarly acceptable technology for kidney stone diagnosis, and is likely to attain popularity in the near future due to low dose of exposure to radiation and cost effectiveness.

Extracorporeal shock wave lithotripsy (ESWL) garnered the major share in global kidney stones management market in 2017. Ureteroscopy was second largest market in terms of treatment, followed by percutaneous nephrolithotomy. These lithotripters have undergone major technological changes in terms of size reduction and targeting systems for effective stone disintegration.

High technology adoption rate and favorable reimbursement scenario is set to accelerate the U.S. kidney stones management market. Furthermore, rising frequency of kidney diseases and high awareness level will propel business growth in the U.S. According to National Institute of Diabetes and Digestive and Kidney Diseases, more than one million kidney stone cases are registered every year in the U.S.

China is set to offer potential growth opportunities for kidney stones management market owing to rapid healthcare infrastructural developments, large patient base, and rising disposable income levels. Introduction of government reforms such as 13th Five Year Plan should promote healthcare facilities in this region offering business opportunities during forecast timeframe.

Various key industry participants in kidney stones management market include Olympus, C. R. Bard, Richard Wolf, Boston Scientific, Coloplast Group, Cook Medical, Dornier Medtech, Karl Storz, Allengers Medical Systems, DireX Group, Elmed Medical Systems, and Medispec among others. Industry players are adopting various strategies such as acquisitions and innovative product launch in order to maintain leadership position in the market.


Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid
1.4.1.2. Unpaid
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Kidney stones management industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Diagnostics trends
2.1.4. Treatment trends
2.1.5. Regional trends
Chapter 3. Kidney Stones Management Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry ecosystem
3.4. Distribution channel analysis
3.5. Industry impact forces
3.5.1. Growth drivers
3.5.1.1. Increasing prevalence and recurrence rate of kidney stones globally
3.5.1.2. Advancements in endoscopy techniques
3.5.1.3. Favorable reimbursement for lithotripsy procedures
3.5.1.4. Inclination towards undergoing minimally invasive surgeries
3.5.1.5. Rising awareness regarding overall kidney health
3.5.2. Industry pitfalls & challenges
3.5.2.1. Lack of treatment awareness in certain countries
3.5.2.2. Potential long-term adverse effects of lithotripsy
3.6. Growth potential analysis
3.6.1. By type
3.6.2. By diagnostics
3.6.3. By treatment
3.7. Regulatory landscape
3.7.1. U.S.
3.7.2. Europe
3.7.3. China
3.8. Porter's analysis
3.9. Company landscape, 2017
3.9.1. Strategy dashboard
3.10. PESTEL analysis
Chapter 4. Kidney Stones Management Market, By Type
4.1. Key segment trends
4.2. Calcium oxalate
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Calcium phosphate
4.3.1. Market estimates and forecast, by region, 2013 - 2024
4.4. Uric acid
4.4.1. Market estimates and forecast, by region, 2013 - 2024
4.5. Struvite
4.5.1. Market estimates and forecast, by region, 2013 - 2024
4.6. Cysteine
4.6.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 5. Kidney Stones Management Market, By Diagnostics
5.1. Key segment trends
5.2. Abdominal X-ray
5.2.1. Market estimates and forecast, by region, 2013 - 2024
5.3. Computed tomography (CT) Scan
5.3.1. Market estimates and forecast, by region, 2013 - 2024
5.4. Ultrasound
5.4.1. Market estimates and forecast, by region, 2013 - 2024
5.5. Abdominal MRI
5.5.1. Market estimates and forecast, by region, 2013 - 2024
5.6. Intravenous Pyleography (IVP)
5.6.1. Market estimates and forecast, by region, 2013 - 2024
5.7. Others
5.7.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 6. Kidney Stones Management Market, By Treatment
6.1. Key segment trends
6.2. Extracorporeal shock wave lithotripsy (ESWL/SWL)
6.2.1. Market estimates and forecast, by region, 2013 - 2024
6.3. Laser lithotripsy/Ureteroscopy
6.3.1. Market estimates and forecast, by region, 2013 - 2024
6.4. Percutaneous Nephrolithotomy
6.4.1. Market estimates and forecast, by region, 2013 - 2024
6.5. Others
6.5.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 7. Kidney Stones Management Market, By Region
7.1. Key segment trends
7.2. North America
7.2.1. Market estimates and forecast, by country, 2013 - 2024
7.2.2. Market estimates and forecast, by type, 2013 - 2024
7.2.3. Market estimates and forecast, by diagnostics, 2013 - 2024
7.2.4. Market estimates and forecast, by treatment, 2013 - 2024
7.2.5. U.S.
7.2.5.1. Market estimates and forecast, by type, 2013 - 2024
7.2.5.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.2.5.3. Market estimates and forecast, by treatment, 2013 - 2024
7.2.6. Canada
7.2.6.1. Market estimates and forecast, by type, 2013 - 2024
7.2.6.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.2.6.3. Market estimates and forecast, by treatment, 2013 - 2024
7.3. Europe
7.3.1. Market estimates and forecast, by country, 2013 - 2024
7.3.2. Market estimates and forecast, by type, 2013 - 2024
7.3.3. Market estimates and forecast, by diagnostics, 2013 - 2024
7.3.4. Market estimates and forecast, by treatment, 2013 - 2024
7.3.5. Germany
7.3.5.1. Market estimates and forecast, by type, 2013 - 2024
7.3.5.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.3.5.3. Market estimates and forecast, by treatment, 2013 - 2024
7.3.6. UK
7.3.6.1. Market estimates and forecast, by type, 2013 - 2024
7.3.6.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.3.6.3. Market estimates and forecast, by treatment, 2013 - 2024
7.3.7. France
7.3.7.1. Market estimates and forecast, by type, 2013 - 2024
7.3.7.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.3.7.3. Market estimates and forecast, by treatment, 2013 - 2024
7.3.8. Italy
7.3.8.1. Market estimates and forecast, by type, 2013 - 2024
7.3.8.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.3.8.3. Market estimates and forecast, by treatment, 2013 - 2024
7.3.9. Spain
7.3.9.1. Market estimates and forecast, by type, 2013 - 2024
7.3.9.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.3.9.3. Market estimates and forecast, by treatment, 2013 - 2024
7.4. Asia Pacific
7.4.1. Market estimates and forecast, by country, 2013 - 2024
7.4.2. Market estimates and forecast, by type, 2013 - 2024
7.4.3. Market estimates and forecast, by diagnostics, 2013 - 2024
7.4.4. Market estimates and forecast, by treatment, 2013 - 2024
7.4.5. China
7.4.5.1. Market estimates and forecast, by type, 2013 - 2024
7.4.5.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.4.5.3. Market estimates and forecast, by treatment, 2013 - 2024
7.4.6. Japan
7.4.6.1. Market estimates and forecast, by type, 2013 - 2024
7.4.6.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.4.6.3. Market estimates and forecast, by treatment, 2013 - 2024
7.4.7. India
7.4.7.1. Market estimates and forecast, by type, 2013 - 2024
7.4.7.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.4.7.3. Market estimates and forecast, by treatment, 2013 - 2024
7.4.8. South Korea
7.4.8.1. Market estimates and forecast, by type, 2013 - 2024
7.4.8.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.4.8.3. Market estimates and forecast, by treatment, 2013 - 2024
7.5. Latin America
7.5.1. Market estimates and forecast, by country, 2013 - 2024
7.5.2. Market estimates and forecast, by type, 2013 - 2024
7.5.3. Market estimates and forecast, by diagnostics, 2013 - 2024
7.5.4. Market estimates and forecast, by treatment, 2013 - 2024
7.5.5. Brazil
7.5.5.1. Market estimates and forecast, by type, 2013 - 2024
7.5.5.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.5.5.3. Market estimates and forecast, by treatment, 2013 - 2024
7.5.6. Mexico
7.5.6.1. Market estimates and forecast, by type, 2013 - 2024
7.5.6.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.5.6.3. Market estimates and forecast, by treatment, 2013 - 2024
7.6. Middle East and Africa
7.6.1. Market estimates and forecast, by country, 2013 - 2024
7.6.2. Market estimates and forecast, by type, 2013 - 2024
7.6.3. Market estimates and forecast, by diagnostics, 2013 - 2024
7.6.4. Market estimates and forecast, by treatment, 2013 - 2024
7.6.5. South Africa
7.6.5.1. Market estimates and forecast, by type, 2013 - 2024
7.6.5.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.6.5.3. Market estimates and forecast, by treatment, 2013 - 2024
7.6.6. Saudi Arabia
7.6.6.1. Market estimates and forecast, by type, 2013 - 2024
7.6.6.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.6.6.3. Market estimates and forecast, by treatment, 2013 - 2024
7.6.7. UAE
7.6.7.1. Market estimates and forecast, by type, 2013 - 2024
7.6.7.2. Market estimates and forecast, by diagnostics, 2013 - 2024
7.6.7.3. Market estimates and forecast, by treatment, 2013 - 2024
Chapter 8. Company Profiles
8.1. Allengers Medical Systems Ltd.
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Boston Scientific Corporation
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. C.R. Bard, Inc.
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Karl Storz GmbH & Co. KG
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. Cook Medical
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Coloplast Group
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. DirexGroup
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Dornier MedTech
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Olympus Corporation
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Richard Wolf GmbH
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. EDAP TMS SA
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
8.12. Elmed Medical Systems
8.12.1. Business overview
8.12.2. Financial data
8.12.3. Product landscape
8.12.4. Strategic outlook
8.12.5. SWOT analysis
8.13. Siemens Healthcare
8.13.1. Business overview
8.13.2. Financial data
8.13.3. Product landscape
8.13.4. Strategic outlook
8.13.5. SWOT analysis
8.14. Medispec Ltd.
8.14.1. Business overview
8.14.2. Financial data
8.14.3. Product landscape
8.14.4. Strategic outlook
8.14.5. SWOT analysis
Data Tables
Table 1 Kidney stones management industry 360 degree synopsis, 2013 - 2024
Table 2 Global kidney stones management market, 2013 - 2024 (USD Million)
Table 3 Global kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 4 Global kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 5 Global kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 6 Global kidney stones management market, by region, 2013 - 2024 (USD Million)
Table 7 Calcium oxalate market by region, 2013 - 2024 (USD Million)
Table 8 Calcium phosphate market by region, 2013 - 2024 (USD Million)
Table 9 Uric acid market by region, 2013 - 2024 (USD Million)
Table 10 Struvite market, by region, 2013 - 2024 (USD Million)
Table 11 Cysteine market, by region, 2013 - 2024, (USD Million)
Table 12 Abdominal X-ray market by region, 2013 - 2024 (USD Million)
Table 13 CT Scan market by region, 2013 - 2024, (USD Million)
Table 14 Ultrasound market by region, 2013 - 2024 (USD Million)
Table 15 Intravenous Pyelography market by region, 2013 - 2024 (USD Million)
Table 16 ESWL market by region, 2013 - 2024 (USD Million)
Table 17 Ureteroscopy market by region, 2013 - 2024 (USD Million)
Table 18 PCNL market by region, 2013 - 2024 (USD Million)
Table 19 Others market by region, 2013 - 2024, (USD Million)
Table 20 North America kidney stones management market, by country, 2013 - 2024 (USD Million)
Table 21 North America kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 22 North America kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 23 North America kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 24 U.S. kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 25 U.S. kidney stones management market, by diagnostics, 2013 - 2024 (USD Million
Table 26 U.S. kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 27 Canada kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 28 Canada kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 29 Canada kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 30 Europe kidney stones management market, by country, 2013 - 2024 (USD Million)
Table 31 Europe kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 32 Europe kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 33 Europe kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 34 Germany kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 35 Germany kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 36 Germany kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 37 UK kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 38 UK kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 39 UK kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 40 France kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 41 France kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 42 France kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 43 Italy kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 44 Italy kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 45 Italy kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 46 Spain kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 47 Spain kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 48 Spain kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 49 Asia-Pacific kidney stones management market, by country, 2013 - 2024 (USD Million)
Table 50 Asia-Pacific kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 51 Asia-Pacific kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 52 Asia-Pacific kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 53 China kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 54 China kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 55 China kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 56 Japan kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 57 Japan kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 58 Japan kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 59 India kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 60 India kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 61 India kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 62 South Korea kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 63 South Korea kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 64 South Korea kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 65 Latin America kidney stones management market, by country, 2013 - 2024 (USD Million)
Table 66 Latin America kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 67 Latin America kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 68 Latin America kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 69 Brazil kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 70 Brazil kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 71 Brazil kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 72 Mexico kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 73 Mexico kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 74 Mexico kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 75 MEA kidney stones management market, by country, 2013 - 2024 (USD Million)
Table 76 MEA kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 77 MEA kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 78 MEA kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 79 South Africa kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 80 South Africa kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 81 South Africa kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 82 Saudi Arabia kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 83 Saudi Arabia kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 84 Saudi Arabia kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Table 85 UAE kidney stones management market, by type, 2013 - 2024 (USD Million)
Table 86 UAE kidney stones management market, by diagnostics, 2013 - 2024 (USD Million)
Table 87 UAE kidney stones management market, by treatment, 2013 - 2024 (USD Million)
Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global kidney stone management market, 2013 - 2024 (USD Million)
FIG. 3 Industry ecosystem
FIG. 4 Distribution channel analysis
FIG. 5 Growth potential analysis, by type
FIG. 6 Growth potential analysis, by diagnostics
FIG. 7 Growth potential analysis, by treatment
FIG. 8 Porter's analysis
FIG. 9 PESTEL analysis
FIG. 10 Company landscape, 2017
FIG. 11 Strategy dashboard, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report